Four New Hospitals from the Netherlands, France and Turkey Win Awards

HIMSS EuropeHIMSS Analytics Europe, subsidiary of HIMSS Europe, awarded yesterday four new hospitals in Europe with Stage 6 Award during the forth edition of eHealth Week, that is taking place in Dublin from the 13th to 15th of May.

The awarded hospitals are: University Medical Center Utrecht, with more than 1.000 beds; Leiden University Medical Center, with 867 beds, both in the Netherlands; the Ankara Hospital in Turkey, in Istanbul, that has 160 beds; and Hôpital Europeen Georges Pompidou in Paris, France, with around 800 beds.

It is the first time that a Turkish hospital is ranked with a Stage 6. In the Netherlands these new awarded hospitals join the previous one awarded in Mallorca in November: Westfriesgasthuis; and in France this new one also joins the Centre Hospitalier Belfort Montbéliard. In total there are 29 hospitals in Europe recognized with the Stage 6, and two hospitals with the Stage 7, one in Germany and one in Spain.

The European EMR Adoption Model (EMRAM) has been adapted to meet the unique needs of European Healthcare Institutions as a methodology for evaluating the progress and impact of electronic medical record systems in hospitals. Tracking their progress in completing eight stages (0‐7), hospitals can review the implementation and utilization of information technology applications with the intent of reaching Stage 7, which represents a superior electronic patient record environment.

Stage 6 & 7 hospitals provide best practices that other healthcare organizations can study as they strive to use EMR applications to improve patient safety, clinical outcomes and patient care delivery efficiency.

Uwe Buddrus, General Manager, HIMSS Analytics Europe, aims: "We are pleased with the steady increase of hospitals reaching Stage 6, and we are happy to welcome a new country in our ranking, what shows the effort that Public Administrations and hospitals are doing to improve the management and patient’s care through the implementation of electronic medical record."

For more information on the Stage 6 & 7 award, please visit:
http://www.himssanalytics.eu

About HIMSS Analytics Europe
HIMSS Analytics Europe (HAE) provides health care organisations, governments and industry with extensive data resources and services about the adoption and use of healthcare information technology in Europe. HAE's offerings include comparative Hospital IT adoption benchmarking, a European‐formulated EMR Adoption Model (EMRAM) scale, and other resources to help hospital directors, IT executives and clinicians compare and measure their progress and how they compare to others. Country level and application specific reports also provide insights into major IT adoption trends and applications.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...